Cargando…

Spectrum of germline and somatic mitochondrial DNA variants in Tuberous Sclerosis Complex

Tuberous Sclerosis Complex (TSC) is caused by loss of function variants in either TSC1 or TSC2 and is characterized by broad phenotypic heterogeneity. Currently, there is limited knowledge regarding the role of the mitochondrial genome (mtDNA) in TSC pathogenesis. In this study, we aimed to determin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giannikou, Krinio, Martin, Katie R., Abdel-Azim, Ahmad G., Pamir, Kaila J., Hougard, Thomas R., Bagwe, Shefali, Tang, Yan, MacKeigan, Jeffrey P., Kwiatkowski, David J., Henske, Elizabeth P., Lam, Hilaire C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923026/ https://www.ncbi.nlm.nih.gov/pubmed/36793390 http://dx.doi.org/10.3389/fgene.2022.917993

Ejemplares similares

Vps34-mediated macropinocytosis in Tuberous Sclerosis Complex 2-deficient cells supports tumorigenesis
por: Filippakis, Harilaos, et al.
Publicado: (2018)

Ultrasensitive profiling of UV-induced mutations identifies thousands of subclinical facial tumors in tuberous sclerosis complex
por: Klonowska, Katarzyna, et al.
Publicado: (2022)

Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion
por: Zarei, Mahsa, et al.
Publicado: (2019)

Serum endostatin levels are associated with diffusion capacity and with tuberous sclerosis- associated lymphangioleiomyomatosis
por: Lamattina, Anthony M., et al.
Publicado: (2019)

The genomic landscape of tuberous sclerosis complex
por: Martin, Katie R., et al.
Publicado: (2017)

MITF is a driver oncogene and potential therapeutic target in kidney angiomyolipoma tumors through transcriptional regulation of CYR61
por: Zarei, Mahsa, et al.
Publicado: (2020)

Renal Cell Carcinoma in Tuberous Sclerosis Complex
por: Henske, Elizabeth P., et al.
Publicado: (2021)

Regulation of YAP by mTOR and autophagy reveals a therapeutic target of tuberous sclerosis complex
por: Liang, Ning, et al.
Publicado: (2014)

Leaving the lysosome behind: novel developments in autophagy inhibition
por: Solitro, Abigail R, et al.
Publicado: (2016)

Computational Analysis of an Autophagy/Translation Switch Based on Mutual Inhibition of MTORC1 and ULK1
por: Szymańska, Paulina, et al.
Publicado: (2015)

Non-canonical functions of the tuberous sclerosis complex-Rheb signalling axis
por: Neuman, Nicole A, et al.
Publicado: (2011)

Drug Inhibition of Redox Factor-1 Restores Hypoxia-Driven Changes in Tuberous Sclerosis Complex 2 Deficient Cells
por: Champion, Jesse D., et al.
Publicado: (2022)

Mitochondrial Morphological Features Are Associated with Fission and Fusion Events
por: Westrate, Laura M., et al.
Publicado: (2014)

Correction: Cytokine Receptor-Like Factor 1 (CRLF1) Protects against 6-Hydroxydopamine Toxicity Independent of the gp130/JAK Signaling Pathway
por: Looyenga, Brendan D., et al.
Publicado: (2014)

Cytokine Receptor-Like Factor 1 (CRLF1) Protects against 6-Hydroxydopamine Toxicity Independent of the gp130/JAK Signaling Pathway
por: Looyenga, Brendan D., et al.
Publicado: (2013)

Mitochondria in cancer: at the crossroads of life and death
por: Fogg, Vanessa C., et al.
Publicado: (2011)

Quantitation of Tissue Amyloid via Fluorescence Spectroscopy Using Controlled Concentrations of Thioflavin-S
por: MacKeigan, Tatiana P., et al.
Publicado: (2023)

Impact of germline and somatic missense variations on drug binding sites
por: Yan, C, et al.
Publicado: (2017)

Notch transactivates Rheb to maintain the multipotency of TSC-null cells
por: Cho, Jun-Hung, et al.
Publicado: (2017)

The tuberous sclerosis proteins regulate formation of the primary cilium via a rapamycin-insensitive and polycystin 1-independent pathway
por: Hartman, Tiffiney R., et al.
Publicado: (2009)

Reciprocal effects of mTOR inhibitors on pro-survival proteins dictate therapeutic responses in tuberous sclerosis complex
por: McNamara, Molly C., et al.
Publicado: (2022)

Unique Metabolic Contexts Sensitize Cancer Cells and Discriminate between Glycolytic Tumor Types
por: Chacon-Barahona, Jonathan A., et al.
Publicado: (2023)

Subependymal giant cell astrocytomas in Tuberous Sclerosis Complex have consistent TSC1/TSC2 biallelic inactivation, and no BRAF mutations
por: Bongaarts, Anika, et al.
Publicado: (2017)

MicroRNA-21 is Induced by Rapamycin in a Model of Tuberous Sclerosis (TSC) and Lymphangioleiomyomatosis (LAM)
por: Trindade, Anil J., et al.
Publicado: (2013)

PI3K-C2α knockdown decreases autophagy and maturation of endocytic vesicles
por: Merrill, Nathan M., et al.
Publicado: (2017)

Analysis of a Mouse Skin Model of Tuberous Sclerosis Complex
por: Guo, Yanan, et al.
Publicado: (2016)

TSC2 rare germline variants in non-tuberous sclerosis patients with neuroendocrine neoplasias
por: Asprino, Paula Fontes, et al.
Publicado: (2017)

Erratum to: An interstitial deletion at 8q23.1-q24.12 associated with Langer-Giedion syndrome/ Trichorhinophalangeal syndrome (TRPS) type II and Cornelia de Lange syndrome 4
por: Selenti, Nikoletta, et al.
Publicado: (2015)

Differential and Common Signatures of miRNA Expression and Methylation in Childhood Central Nervous System Malignancies: An Experimental and Computational Approach
por: Lambrou, George I., et al.
Publicado: (2021)

Germline Variation Controls the Architecture of Somatic Alterations in Tumors
por: Dworkin, Amy M., et al.
Publicado: (2010)

Computational model for autophagic vesicle dynamics in single cells
por: Martin, Katie R., et al.
Publicado: (2013)

Kidney intercalated cells and the transcription factor FOXi1 drive cystogenesis in tuberous sclerosis complex
por: Barone, Sharon, et al.
Publicado: (2021)

Downregulation of the Mitochondrial Phosphatase PTPMT1 Is Sufficient to Promote Cancer Cell Death
por: Niemi, Natalie M., et al.
Publicado: (2013)

Persistent Mitochondrial Hyperfusion Promotes G2/M Accumulation and Caspase-Dependent Cell Death
por: Westrate, Laura M., et al.
Publicado: (2014)

Identification of Small Molecule Inhibitors of PTPσ through an Integrative Virtual and Biochemical Approach
por: Martin, Katie R., et al.
Publicado: (2012)

Lysosomal regulation of cholesterol homeostasis in tuberous sclerosis complex is mediated via NPC1 and LDL-R
por: Filippakis, Harilaos, et al.
Publicado: (2017)

Real-Time Monitoring of Tumorigenesis, Dissemination, & Drug Response in a Preclinical Model of Lymphangioleiomyomatosis/Tuberous Sclerosis Complex
por: Liu, Fangbing, et al.
Publicado: (2012)

DDK Promotes Tumor Chemoresistance and Survival via Multiple Pathways
por: Sasi, Nanda Kumar, et al.
Publicado: (2017)

Germline competent mesoderm: the substrate for vertebrate germline and somatic stem cells?
por: Savage, Aaron M., et al.
Publicado: (2021)

The Pseudophosphatase MK-STYX Physically and Genetically Interacts with the Mitochondrial Phosphatase PTPMT1
por: Niemi, Natalie M., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hqk9l3stgd5u1c5qrt7kh246ms